AlphaFold predicted structure
KCNH5 · Q8NCM2

Mean pLDDT
72.1/ 100
Confident
988 residues
Confidence breakdown
- Very high(≥ 90)39%
- Confident(70–90)27%
- Low(50–70)7%
- Very low(< 50)27%
AlphaFold (Jumper et al., 2021) · CC BY 4.0
potassium voltage-gated channel subfamily H member 5
Annotations refreshed 1 month ago.
Diagnostic Grade (Green)
DDG2P
MONOALLELIC, autosomal or pseudoautosomal, imprinted status unknownEarly onset or syndromic epilepsy
MONOALLELIC, autosomal or pseudoautosomal, NOT imprintedIntellectual disability
MONOALLELIC, autosomal or pseudoautosomal, NOT imprinteddevelopmental and epileptic encephalopathy 112
myasthenia gravis
multiple sclerosis
Lambert-Eaton myasthenic syndrome
genetic developmental and epileptic encephalopathy
early-infantile DEE
developmental and epileptic encephalopathy, 12
congenital myasthenic syndrome
Congenital myasthenic syndromes
Muscle weakness
Score is the Open Targets composite evidence score (0-1). Higher = stronger gene-disease association.
Voltage-gated delayed rectifier potassium channel KCNH5
Pore-forming (alpha) subunit of a voltage-gated delayed rectifier potassium channel that mediates outward-rectifying potassium currents which, on depolarization, reaches a steady-state level and do not inactivate (PubMed:11943152, PubMed:12135768, PubMed:24133262, PubMed:36928654). The kinetic is characterized by a slow activation time course and a small voltage dependence of the activation time constants, therefore, starts to open at more negative voltages (PubMed:11943152, PubMed:12135768). The activation kinetics depend on the prepulse potential and external divalent cation concentration (PubMed:11943152, PubMed:24133262). The time course of activation is biphasic with a fast and a slowly activating current component (PubMed:11943152, PubMed:12135768, PubMed:36928654). With negative prepulses, the current activation is delayed and slowed down several fold, whereas more positive prepulses speed up activation, therefore the activation rate depends on holding potential (PubMed:11943152, PubMed:12135768, PubMed:36928654)
Curated MONDO disease pages that list KCNH5 among their top associated genes.
KCNH5 · Q8NCM2

Mean pLDDT
72.1/ 100
Confident
988 residues
Confidence breakdown
AlphaFold (Jumper et al., 2021) · CC BY 4.0